NuCana PLC - ESG Rating & Company Profile powered by AI
If you work at NuCana PLC and you would like to use your Sustainability aseessment, please get in touch. The assessment of NuCana PLC is assembled by All Street Sevva using proprietary Cognitive Robots. The page is a free E,S&G analysis for NuCana PLC.
NuCana PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.4; made up of an environmental score of 8.0, social score of 3.2 and governance score of 8.0.
6.4
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 389 | WuXi Biologics (Cayman) Inc | 6.6 | High |
| 401 | Oxford Cannabinoid Technologies Holdings PLC | 6.5 | High |
| 402 | NuCana PLC | 6.4 | High |
| 402 | Capricor Therapeutics Inc | 6.4 | High |
| 402 | Alembic Pharmaceuticals Ltd | 6.4 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does NuCana PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes NuCana PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes NuCana PLC report the average age of the workforce?
Sign up for free to unlockDoes NuCana PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes NuCana PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes NuCana PLC disclose cybersecurity risks?
Sign up for free to unlockDoes NuCana PLC offer flexible work?
Sign up for free to unlockDoes NuCana PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes NuCana PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes NuCana PLC conduct supply chain audits?
Sign up for free to unlockDoes NuCana PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes NuCana PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes NuCana PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes NuCana PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes NuCana PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes NuCana PLC disclose water use targets?
Sign up for free to unlockDoes NuCana PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid NuCana PLC have a product recall in the last two years?
Sign up for free to unlockDoes NuCana PLC disclose incidents of discrimination?
Sign up for free to unlockDoes NuCana PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas NuCana PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes NuCana PLC disclose parental leave metrics?
Sign up for free to unlockDoes NuCana PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes NuCana PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes NuCana PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes NuCana PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes NuCana PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes NuCana PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs NuCana PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes NuCana PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes NuCana PLC disclose its waste policy?
Sign up for free to unlockDoes NuCana PLC report according to TCFD requirements?
Sign up for free to unlockDoes NuCana PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes NuCana PLC disclose energy use targets?
Sign up for free to unlockDoes NuCana PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes NuCana PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for NuCana PLC
These potential risks are based on the size, segment and geographies of the company.
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients with recurrent ovarian cancer; Phase Ib clinical trials for the treatment of patients with biliary tract cancer; Phase II clinical trial for the treatment of patients with platinum-resistant ovarian cancer; and Phase III clinical trial for the treatment of patients with pancreatic cancer. The company is also developing NUC-3373, a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil, which is in Phase I clinical trial for the treatment of patients with advanced solid tumors and in a Phase 1b/2 clinical trial for patients with advanced colorectal cancer; and NUC-7738, a nucleoside analog that is in Phase 1/2 clinical trial for the treatment of patients with advanced solid tumors and hematological tumors. It has a research, collaboration, and license agreement with Cardiff University and University College Cardiff Consultants Ltd. for the design, synthesis, characterization, and evaluation of ProTides; and an assignment, license, and collaboration agreement with Cardiff ProTides Ltd. The company was formerly known as NuCana BioMed Limited and changed its name to NuCana plc in August 2017. NuCana plc was incorporated in 1997 and is headquartered in Edinburgh, the United Kingdom.